SCHEMBL8645209

SCHEMBL8645209

O=C(O)C1CN(CCc2ccc(C(F)(F)F)cc2)C=N1

nearest known ligand 0.42

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
S1PR1 P21453 2/20 0.40
GRK5 P34947 1/20 0.40
CDK8 P49336 1/20 0.40
S1PR5 Q9H228 1/20 0.40
GUSB P08236 1/20 0.40
HPSE Q9Y251 1/20 0.40
FLT1 P17948 2/20 0.39
KDR P35968 2/20 0.39
GAA P10253 1/20 0.39
NOTUM Q6P988 1/20 0.39
FFAR1 O14842 1/20 0.38
DAO P14920 1/20 0.38
SIRT2 Q8IXJ6 1/20 0.37
SIRT1 Q96EB6 1/20 0.37
HDAC1 Q13547 1/20 0.37
HDAC8 Q9BY41 1/20 0.37
PDPK1 O15530 1/20 0.37
KCNH2 Q12809 1/20 0.37
TAAR1 Q96RJ0 1/20 0.36
PLAAT3 P53816 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2801753 0.70 NR3C2 (0.41) S1PR1GRK5CDK8S1PR5GUSB
Hydrochloric Acid SCHEMBL28626980 0.67 SIRT2 (0.44) GAADAOSIRT2SIRT1KCNH2
SCHEMBL21381765 0.66 MAOB (0.49) S1PR1GRK5CDK8S1PR5FFAR1
SCHEMBL30323075 0.65 GAA (0.56) GAADAOTAAR1
SCHEMBL26778342 0.65 GAA (0.56) GAADAOTAAR1
SCHEMBL117230 0.64 FFAR1 (0.73) FFAR1HDAC1HDAC8PDPK1TAAR1
SCHEMBL31098655 0.63 FFAR1 (0.55) FFAR1HDAC1HDAC8PDPK1TAAR1
SCHEMBL28150824 0.63 SRD5A2 (0.72) FFAR1HDAC1HDAC8PDPK1TAAR1
SCHEMBL27708537 0.62 TAAR1 (0.47) GAADAOTAAR1
SCHEMBL13221512 0.62 S1PR5 (0.77) S1PR1GRK5CDK8S1PR5

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-5847135-A Inhibitors of interleukin-1β converting enzyme VERTEX PHARMACEUTICALS, INCORPORATED (US) 1998-12-08 US disclosed
US-5716929-A THERAPY FOR INFLAMMATION, AUTOIMMUNE DISEASES VERTEX PHARMACEUTICALS, INC. (US) 1998-02-10 US disclosed